180 related articles for article (PubMed ID: 35394718)
1. [SYSADOA place in degenerative-dystrophic joints diseases treatment of neurological practice from the standpoint of evidence-based medicine].
Shavlovskaya OA
Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(3):38-45. PubMed ID: 35394718
[TBL] [Abstract][Full Text] [Related]
2. Appropriateness of clinical criteria for the use of SYmptomatic Slow-Acting Drug for OsteoArthritis (SYSADOA). A Delphi Method Consensus initiative among experts in Italy.
Bernetti A; Mangone M; Villani C; Alviti F; Valeo M; Grassi MC; Migliore A; Viora U; Adriani E; Quirino N; Fioravanti A; Paoloni M
Eur J Phys Rehabil Med; 2019 Oct; 55(5):658-664. PubMed ID: 31106560
[TBL] [Abstract][Full Text] [Related]
3. A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis-From evidence-based medicine to the real-life setting.
Bruyère O; Cooper C; Pelletier JP; Maheu E; Rannou F; Branco J; Luisa Brandi M; Kanis JA; Altman RD; Hochberg MC; Martel-Pelletier J; Reginster JY
Semin Arthritis Rheum; 2016 Feb; 45(4 Suppl):S3-11. PubMed ID: 26806188
[TBL] [Abstract][Full Text] [Related]
4. Effects of glucosamine sulfate on the use of rescue non-steroidal anti-inflammatory drugs in knee osteoarthritis: Results from the Pharmaco-Epidemiology of GonArthroSis (PEGASus) study.
Rovati LC; Girolami F; D'Amato M; Giacovelli G
Semin Arthritis Rheum; 2016 Feb; 45(4 Suppl):S34-41. PubMed ID: 26632505
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of glucosamine sulfate in the management of osteoarthritis: Evidence from real-life setting trials and surveys.
Bruyère O; Altman RD; Reginster JY
Semin Arthritis Rheum; 2016 Feb; 45(4 Suppl):S12-7. PubMed ID: 26806187
[TBL] [Abstract][Full Text] [Related]
6. 2021 revised algorithm for the management of knee osteoarthritis-the Chinese viewpoint.
Zhang Z; Huang C; Cao Y; Mu R; Zhang MC; Xing D; Fan D; Ding Y; Guo J; Hou Y; Jianhao L; Veronese N; Reginster JY; Bruyere O; Cavalier E; Zhang H
Aging Clin Exp Res; 2021 Aug; 33(8):2141-2147. PubMed ID: 34189714
[TBL] [Abstract][Full Text] [Related]
7. Clinical review of chondroitin sulfate in osteoarthritis.
Uebelhart D
Osteoarthritis Cartilage; 2008; 16 Suppl 3():S19-21. PubMed ID: 18674931
[TBL] [Abstract][Full Text] [Related]
8. [Chondroitin sulfate in therapy osteoarthritis chronic pain patients according to actual clinical recommendations].
Shavlovskaya OA
Ter Arkh; 2021 Dec; 93(12):1551-1555. PubMed ID: 36286687
[TBL] [Abstract][Full Text] [Related]
9. Commentary on recent therapeutic guidelines for osteoarthritis.
Cutolo M; Berenbaum F; Hochberg M; Punzi L; Reginster JY
Semin Arthritis Rheum; 2015 Jun; 44(6):611-7. PubMed ID: 25677861
[TBL] [Abstract][Full Text] [Related]
10. Inappropriate claims from non-equivalent medications in osteoarthritis: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
Bruyère O; Cooper C; Al-Daghri NM; Dennison EM; Rizzoli R; Reginster JY
Aging Clin Exp Res; 2018 Feb; 30(2):111-117. PubMed ID: 29177637
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of efficacy and safety of glucosamine sulfate, chondroitin sulfate, and their combination regimen in the management of knee osteoarthritis: a systematic review and meta-analysis.
Rabade A; Viswanatha GL; Nandakumar K; Kishore A
Inflammopharmacology; 2024 Jun; 32(3):1759-1775. PubMed ID: 38581640
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological Management of Osteoarthritis With a Focus on Symptomatic Slow-Acting Drugs: Recommendations From Leading Russian Experts.
Alexander LAM; Ln D; Eg Z; Is D; Ay K; Ss R; Ea T; Sp Y; Ez Y; L G
J Clin Rheumatol; 2021 Dec; 27(8):e533-e539. PubMed ID: 32732520
[TBL] [Abstract][Full Text] [Related]
13. 2019 revised algorithm for the management of knee osteoarthritis: the Southeast Asian viewpoint.
Yeap SS; Tanavalee A; Perez EC; Tan MP; Reyes BHM; Lee JK; Norhamdan MY; Vista ES; Chan WS; Cong SB; Tam PTT; Kaufman JM; Reginster JY; Veronese N; Penserga E
Aging Clin Exp Res; 2021 May; 33(5):1149-1156. PubMed ID: 33774784
[TBL] [Abstract][Full Text] [Related]
14. [Comparative analysis of the use of symptomatic slow acting drugs for osteoarthritis containing chondroitin sulfate or affecting its biosynthesis in patients with non-specific low back pain].
Sarvilina IV; Danilov AB
Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(1):81-96. PubMed ID: 36719123
[TBL] [Abstract][Full Text] [Related]
15. A review of evidence-based medicine for glucosamine and chondroitin sulfate use in knee osteoarthritis.
Vangsness CT; Spiker W; Erickson J
Arthroscopy; 2009 Jan; 25(1):86-94. PubMed ID: 19111223
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system.
Bruyère O; Burlet N; Delmas PD; Rizzoli R; Cooper C; Reginster JY
BMC Musculoskelet Disord; 2008 Dec; 9():165. PubMed ID: 19087296
[TBL] [Abstract][Full Text] [Related]
17. [Chondroitin sulfate role in the complex rehabilitation of elderly people with chronic pain syndrome].
Shavlovskaya OA; Razumov AN; Bokova IA; Shavlovskiy NI; Yukhnovskaya YD
Vopr Kurortol Fizioter Lech Fiz Kult; 2021; 98(1):71-78. PubMed ID: 33605133
[TBL] [Abstract][Full Text] [Related]
18. The clinical effectiveness of glucosamine and chondroitin supplements in slowing or arresting progression of osteoarthritis of the knee: a systematic review and economic evaluation.
Black C; Clar C; Henderson R; MacEachern C; McNamee P; Quayyum Z; Royle P; Thomas S
Health Technol Assess; 2009 Nov; 13(52):1-148. PubMed ID: 19903416
[TBL] [Abstract][Full Text] [Related]
19. Endorsement by Central European experts of the revised ESCEO algorithm for the management of knee osteoarthritis.
Kucharz EJ; Szántó S; Ivanova Goycheva M; Petronijević M; Šimnovec K; Domżalski M; Gallelli L; Kamenov Z; Konstantynowicz J; Radunović G; Šteňo B; Stoilov R; Stok R; Vrana R; Bruyère O; Cooper C; Reginster JY
Rheumatol Int; 2019 Jul; 39(7):1117-1123. PubMed ID: 31129712
[TBL] [Abstract][Full Text] [Related]
20. Comparative Analyses of Pharmaceuticals or Food Supplements Containing Chondroitin Sulfate: Are Their Bioactivities Equivalent?
Stellavato A; Restaino OF; Vassallo V; Finamore R; Ruosi C; Cassese E; De Rosa M; Schiraldi C
Adv Ther; 2019 Nov; 36(11):3221-3237. PubMed ID: 31494830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
